Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Florida
Pfizer
Jonsson Comprehensive Cancer Center
Cancer Research UK
Washington University School of Medicine
Cedars-Sinai Medical Center
Celgene
National Cancer Institute (NCI)